Cipla | CIPLA - Zahlungsmittel Und Äquivalente

Aktienkurs
1,286.70
Täglich Wechseln
4.80 0.37%
Monatlich
-4.67%
Jährlich
-14.71%
Q1 Prognose
1,289.06




Zahlungsmittel Und Äquivalente Veränderung Datum
Arca Biopharma USD 91.25M 25.86M 2025-09
aTyr Pharma USD 6.15M 11.07M 2025-09
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Capricor Therapeutics USD 287.85M 268.34M 2025-12
Cara Therapeutics USD 20.65M 13.57M 2025-06
Cipla INR 7.96B 39.9M 2025-09
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Immunic USD 35.13M 20.18M 2025-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
TherapeuticsMD 523K 89K 2024-06
UPL INR 41.52B 53.85B 2025-09